TalkSooner and Baldwin Community School collaborate on youth vaping education

Sep.02.2022
TalkSooner and Baldwin Community School collaborate on youth vaping education
TalkSooner works with Michigan schools to educate parents and teens about the dangers and risks of electronic cigarette addiction.

As the number of teenagers vaping across the United States continues to rise, many school districts in West Michigan are taking measures to educate families about the dangers of addiction, including the Baldwin Community Schools.


TalkSooner is an organization dedicated to helping parents and teenagers understand the dangers of drug abuse. They are currently working in collaboration with Baldwin School to educate and facilitate discussions on the topic of teen use of electronic cigarettes.


This organization is a cooperative organization between Allegan County, Berrien County, Kent County, Muskegon County, and Ottawa County in western Michigan. It is coordinated by the West Michigan Shoreline Regional Development Commission (now known as the West Michigan Shoreline Regional Entity).


Recently, the organization partnered with the Baldwin Community School to launch a new education tool that will serve those who can provide information on e-cigarette use for teenagers.


This vehicle made its debut in the area on August 24th. The car displays information in English on one side and in Spanish on the other side through TalkSooner.


According to data from the 2018 National Youth Tobacco Survey (NYTS), the use of electronic cigarettes among current middle and high school students increased by 48% between 2017 and 2018. As of 2018, over 3.6 million children are currently using electronic cigarettes.


Griffin stated, "If you look at smoking, we almost didn't see the number of people smoking in the 50s and 60s because we not only had prevention, but education," Griffin said. "We now know smoking brings harm and can change our lives. We hope to ensure that we take the same measures for children who start vaping at 13 or 14 years old, to catch and quit this habit early or at least make them aware of the dangers that come with it.


On June 4, 2019, Governor Gretchen Whitmer signed Senate Bills 106 and 155, prohibiting the sale and possession of electronic cigarettes to anyone under the age of 18. In December of the same year, federal legislation was signed, raising the legal age to purchase or use tobacco products, including e-cigarettes, to 21. Despite these measures, many remain skeptical of the number of young students still using e-cigarettes.


Griffin has seen firsthand how difficult it is for parents to talk to teenagers about using e-cigarettes after her own child used them. "Preventative education seems to be the most important, not just for your physical health, but also for your mental and overall well-being," she said. "Even in the most educated households, there is still susceptibility to the pressures of e-cigarettes and such. I always encourage parents to have open conversations with their children, discussing their own struggles or choices made by young people. I also suggest trying to find out why they are interested in e-cigarettes or the root cause of their decision to use them.


In September 2018, the US Food and Drug Administration (FDA) sent over 1,300 warning letters and civil monetary penalties to retailers illegally selling e-cigarette products to minors, with the majority being blu, JUUL, Logic, MarkTen XL, and Vuse; this marked the FDA's largest coordinated enforcement effort to date.


According to the Centers for Disease Control and Prevention, some e-cigarette products have labels that do not disclose that they contain nicotine, while some e-cigarette liquids marketed as containing 0% nicotine have been found to contain nicotine.


Using nicotine during adolescence can damage the parts of the brain that control attention, learning, emotions, and impulse control, and may also impair brain development in teenagers. This damage can persist into the mid-20s.


Statement


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not reflect the views of 2FIRSTS and we cannot verify the accuracy or truthfulness of its contents. The compilation of this article is only intended for industry-related research and exchange.


Due to limitations in the level of translation, the translated article may not express exactly the same meaning as the original. Please refer to the original text for accuracy.


2FIRSTS fully aligns its statements and position with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or international issues.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14